chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 87.0
Sex: M
Vaccine: COVID19, FLU4, RSV
Symptoms: Computerised tomogram, Fatigue, Impaired driving ability, Magnetic resonance imaging, Mobility decreased
Clinical narrative: He got his vaccines, the followoing day he had a sore arm.  The next day he was driving his car and he knew somethign was wrong.  He came to a rotary and did not go around it and went over it.  He did not hit anything, knew that he was in trouble.  He went to a gas station and got half out of the car, and grabbed the steering wheel and could not move his arm.  Attendend asked him if he was OK and he could not answer, he called 911 and he was taken to the hospital by ambulance.  He went to Hospital.  Once he got to the ER in about 3 hours he could speak and he could move his arm.  They informed him that he had had a stroke.  He was admitted to the hospital, and was there for 4 days.  He did have blood work, MRI's and CAT scans.  He was put on Plavix for 21 days and then they wanted him to wear a heart monitor for 30 days, but he was going to travel in 20 days and he was told to see his cardiologist and he was put on a 14 day heart monitor and still has 6 days to go with the heart monitor.  He is feeling tired at this point, more tired than he usually is.  He did have some chest discomfort that is recorded on the event monitor that he is wearing.
Age: 42.0
Sex: M
Vaccine: FLU4
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient received double dose of vaccine. Monitored for adverse reactions. None noted. Will continue to monitor.
Age: 73.0
Sex: M
Vaccine: FLUA4
Symptoms: Inadvertent injection air bubble
Clinical narrative: patient states there was a bubble at the injection site
Age: 71.0
Sex: M
Vaccine: COVID19-2, VARZOS
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: Moderna vaccine given was Spikevax.  Symptoms started to occur after approximately 1 week and are as follows: Left chest area rash from breast area down 6-7 inches. Rash is itchy, red, non -blistering Left inner upper arm rash, rash is itchy, red , non-blistering Left inner forearm rash from wrist to elbow, rash is itchy, red, non-blistering Patient has been applying Benadryl spray to calm itch.  Patient had Dr. appointment today just advised to keep applying Benadryl spray and that rashes should subside within a couple weeks.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood gases, Blood lactic acid normal, Blood pH normal, C-reactive protein increased
Clinical narrative: Agency is a 61 y.o. male patient, CNP with history of MS, Trigeminal neuralgia, Depression, anxiety presented to Hospital with weakness, confusion, home positive Covid test .   Covid virus infection Acute Metabolic Encephalopathy - resolved Weakness  Mild Hyponatremia  P/w P/w 2 days of nasal congestion, cough,  sore throat, SOB, myalgias, weakness, high fevers , nausea, poor appetite, wife reports confusion .  Encephalopathy likely from Covid, weakness complicated by MS  Pt is vaccinated x 4 Date of onset of symptoms: 10/9/23  Date of covid positive test: 10/10/23  Oxygen requirements on admission: none  Current oxygen requirements: none  Medical therapy: not a candidate febrile on arrival 101.2, HR 98, RR 18, BP 11/62, satting 98% on RA Initial CBC w WBC 6, LA normal, troponin normal VBG 7.37/46  CXR: No acute process CT head white matter changes , could be amll vessel ischemic change or demyelinating process (h/o MS) CRP 110 => 143, discussed this with patient and dexamethasone initiated for 10 days Albuterol, robitussin-DM, tylenol PRN Lasix PRN for dry lung strategy, monitor I&Os Encourage IS use Contact precautions Lovenox  for DVT ppx   Progressive non-relapsing MS Trigeminal neuralgia  Neuropathy Was following with neurologist, unsure if he has established care here Continue Tegretol and Gabapentin Also takes Norco PRN, last filled 10/2/23 for 30 days Describes some worsened leg weakness today so will consult Neurology to assess for potential MS flare, appreciate assistance  Depression/Anxiety Resume home meds    Asthma Resume singulair
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Computerised tomogram head abnormal, Condition aggravated, Confusional state
Clinical narrative: Agency is a 61 y.o. male patient, CNP with history of MS, Trigeminal neuralgia, Depression, anxiety presented to Hospital with weakness, confusion, home positive Covid test .   Covid virus infection Acute Metabolic Encephalopathy - resolved Weakness  Mild Hyponatremia  P/w P/w 2 days of nasal congestion, cough,  sore throat, SOB, myalgias, weakness, high fevers , nausea, poor appetite, wife reports confusion .  Encephalopathy likely from Covid, weakness complicated by MS  Pt is vaccinated x 4 Date of onset of symptoms: 10/9/23  Date of covid positive test: 10/10/23  Oxygen requirements on admission: none  Current oxygen requirements: none  Medical therapy: not a candidate febrile on arrival 101.2, HR 98, RR 18, BP 11/62, satting 98% on RA Initial CBC w WBC 6, LA normal, troponin normal VBG 7.37/46  CXR: No acute process CT head white matter changes , could be amll vessel ischemic change or demyelinating process (h/o MS) CRP 110 => 143, discussed this with patient and dexamethasone initiated for 10 days Albuterol, robitussin-DM, tylenol PRN Lasix PRN for dry lung strategy, monitor I&Os Encourage IS use Contact precautions Lovenox  for DVT ppx   Progressive non-relapsing MS Trigeminal neuralgia  Neuropathy Was following with neurologist, unsure if he has established care here Continue Tegretol and Gabapentin Also takes Norco PRN, last filled 10/2/23 for 30 days Describes some worsened leg weakness today so will consult Neurology to assess for potential MS flare, appreciate assistance  Depression/Anxiety Resume home meds    Asthma Resume singulair
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Dyspnoea, Hyponatraemia, Metabolic encephalopathy
Clinical narrative: Agency is a 61 y.o. male patient, CNP with history of MS, Trigeminal neuralgia, Depression, anxiety presented to Hospital with weakness, confusion, home positive Covid test .   Covid virus infection Acute Metabolic Encephalopathy - resolved Weakness  Mild Hyponatremia  P/w P/w 2 days of nasal congestion, cough,  sore throat, SOB, myalgias, weakness, high fevers , nausea, poor appetite, wife reports confusion .  Encephalopathy likely from Covid, weakness complicated by MS  Pt is vaccinated x 4 Date of onset of symptoms: 10/9/23  Date of covid positive test: 10/10/23  Oxygen requirements on admission: none  Current oxygen requirements: none  Medical therapy: not a candidate febrile on arrival 101.2, HR 98, RR 18, BP 11/62, satting 98% on RA Initial CBC w WBC 6, LA normal, troponin normal VBG 7.37/46  CXR: No acute process CT head white matter changes , could be amll vessel ischemic change or demyelinating process (h/o MS) CRP 110 => 143, discussed this with patient and dexamethasone initiated for 10 days Albuterol, robitussin-DM, tylenol PRN Lasix PRN for dry lung strategy, monitor I&Os Encourage IS use Contact precautions Lovenox  for DVT ppx   Progressive non-relapsing MS Trigeminal neuralgia  Neuropathy Was following with neurologist, unsure if he has established care here Continue Tegretol and Gabapentin Also takes Norco PRN, last filled 10/2/23 for 30 days Describes some worsened leg weakness today so will consult Neurology to assess for potential MS flare, appreciate assistance  Depression/Anxiety Resume home meds    Asthma Resume singulair
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Multiple sclerosis, Muscular weakness, Myalgia, Nasal congestion, Nausea
Clinical narrative: Agency is a 61 y.o. male patient, CNP with history of MS, Trigeminal neuralgia, Depression, anxiety presented to Hospital with weakness, confusion, home positive Covid test .   Covid virus infection Acute Metabolic Encephalopathy - resolved Weakness  Mild Hyponatremia  P/w P/w 2 days of nasal congestion, cough,  sore throat, SOB, myalgias, weakness, high fevers , nausea, poor appetite, wife reports confusion .  Encephalopathy likely from Covid, weakness complicated by MS  Pt is vaccinated x 4 Date of onset of symptoms: 10/9/23  Date of covid positive test: 10/10/23  Oxygen requirements on admission: none  Current oxygen requirements: none  Medical therapy: not a candidate febrile on arrival 101.2, HR 98, RR 18, BP 11/62, satting 98% on RA Initial CBC w WBC 6, LA normal, troponin normal VBG 7.37/46  CXR: No acute process CT head white matter changes , could be amll vessel ischemic change or demyelinating process (h/o MS) CRP 110 => 143, discussed this with patient and dexamethasone initiated for 10 days Albuterol, robitussin-DM, tylenol PRN Lasix PRN for dry lung strategy, monitor I&Os Encourage IS use Contact precautions Lovenox  for DVT ppx   Progressive non-relapsing MS Trigeminal neuralgia  Neuropathy Was following with neurologist, unsure if he has established care here Continue Tegretol and Gabapentin Also takes Norco PRN, last filled 10/2/23 for 30 days Describes some worsened leg weakness today so will consult Neurology to assess for potential MS flare, appreciate assistance  Depression/Anxiety Resume home meds    Asthma Resume singulair
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia, SARS-CoV-2 test positive, Troponin normal, White blood cell count normal
Clinical narrative: Agency is a 61 y.o. male patient, CNP with history of MS, Trigeminal neuralgia, Depression, anxiety presented to Hospital with weakness, confusion, home positive Covid test .   Covid virus infection Acute Metabolic Encephalopathy - resolved Weakness  Mild Hyponatremia  P/w P/w 2 days of nasal congestion, cough,  sore throat, SOB, myalgias, weakness, high fevers , nausea, poor appetite, wife reports confusion .  Encephalopathy likely from Covid, weakness complicated by MS  Pt is vaccinated x 4 Date of onset of symptoms: 10/9/23  Date of covid positive test: 10/10/23  Oxygen requirements on admission: none  Current oxygen requirements: none  Medical therapy: not a candidate febrile on arrival 101.2, HR 98, RR 18, BP 11/62, satting 98% on RA Initial CBC w WBC 6, LA normal, troponin normal VBG 7.37/46  CXR: No acute process CT head white matter changes , could be amll vessel ischemic change or demyelinating process (h/o MS) CRP 110 => 143, discussed this with patient and dexamethasone initiated for 10 days Albuterol, robitussin-DM, tylenol PRN Lasix PRN for dry lung strategy, monitor I&Os Encourage IS use Contact precautions Lovenox  for DVT ppx   Progressive non-relapsing MS Trigeminal neuralgia  Neuropathy Was following with neurologist, unsure if he has established care here Continue Tegretol and Gabapentin Also takes Norco PRN, last filled 10/2/23 for 30 days Describes some worsened leg weakness today so will consult Neurology to assess for potential MS flare, appreciate assistance  Depression/Anxiety Resume home meds    Asthma Resume singulair
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: White matter lesion
Clinical narrative: Agency is a 61 y.o. male patient, CNP with history of MS, Trigeminal neuralgia, Depression, anxiety presented to Hospital with weakness, confusion, home positive Covid test .   Covid virus infection Acute Metabolic Encephalopathy - resolved Weakness  Mild Hyponatremia  P/w P/w 2 days of nasal congestion, cough,  sore throat, SOB, myalgias, weakness, high fevers , nausea, poor appetite, wife reports confusion .  Encephalopathy likely from Covid, weakness complicated by MS  Pt is vaccinated x 4 Date of onset of symptoms: 10/9/23  Date of covid positive test: 10/10/23  Oxygen requirements on admission: none  Current oxygen requirements: none  Medical therapy: not a candidate febrile on arrival 101.2, HR 98, RR 18, BP 11/62, satting 98% on RA Initial CBC w WBC 6, LA normal, troponin normal VBG 7.37/46  CXR: No acute process CT head white matter changes , could be amll vessel ischemic change or demyelinating process (h/o MS) CRP 110 => 143, discussed this with patient and dexamethasone initiated for 10 days Albuterol, robitussin-DM, tylenol PRN Lasix PRN for dry lung strategy, monitor I&Os Encourage IS use Contact precautions Lovenox  for DVT ppx   Progressive non-relapsing MS Trigeminal neuralgia  Neuropathy Was following with neurologist, unsure if he has established care here Continue Tegretol and Gabapentin Also takes Norco PRN, last filled 10/2/23 for 30 days Describes some worsened leg weakness today so will consult Neurology to assess for potential MS flare, appreciate assistance  Depression/Anxiety Resume home meds    Asthma Resume singulair
Age: 64.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Back pain, Burning sensation, Erythema, Myalgia
Clinical narrative: The first hour and days after receiving the flu vaccine had a red area with swelling  burning and rash on arm that received flu vaccine. The area was hot but she never had fever.  Several days later experiencing muscle, back, knee, and ankle pain and tingling.
Age: 64.0
Sex: F
Vaccine: FLU4
Symptoms: Paraesthesia, Peripheral swelling, Rash, Skin warm
Clinical narrative: The first hour and days after receiving the flu vaccine had a red area with swelling  burning and rash on arm that received flu vaccine. The area was hot but she never had fever.  Several days later experiencing muscle, back, knee, and ankle pain and tingling.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Atelectasis, Blood creatine phosphokinase increased, Blood culture negative, COVID-19
Clinical narrative: HMS DISCHARGE SUMMARY -- Hospital     Admitted: 9/29/2023 Discharge Date: 10/02/23    PCP Handoff    Recommended Outpatient Testing o None   Results Pending At Discharge o None       Clinical Summary  Patient is a 72 y.o. male patient of MD with history of Parkinson's disease, hyperlipidemia presented to Hospital with cough, sore throat for a few days and severe weakness that started earlier today.  Found to be COVID positive at PCP office.  Found to have elevated CPK likely due to underlying COVID infection and decreased fluid intake.  CPK trending down with IV fluids.  Sore throat resolved.  Read by therapy with no further recommendations.  To be discharged home with outpatient follow-up   Covid-19 Virus Infection with pneumonia  Date of onset of symptoms: 9/27/23 Symptoms present on admission: Cough, sore throat Date of covid positive test: 9/29/23 Imaging: Chest x-ray 9/29 with minimal atelectasis of the left lung base Oxygen requirements on admission: None Current oxygen requirements: room air Medical therapy: Continued outpatient Paxlovid Anticipated special isolation end date: 10/7/23   Possible aspiration pneumonia/superimposed bacterial pneumonia Sepsis, POA (tachycardia, tachypnea, leukocytosis) Patient says he has some issues with swallowing related to the Parkinson's disease Weakness has been much worse due to the COVID Significant productive cough, sepsis on presentation Chest x-ray without any infiltrate CT soft tissue neck done for severe sore throat without any acute findings.  Blood cultures no growth today SLP consulted for swallow evaluation-appreciate recommendations.  No further speech therapy needs or diet modifications.   Rhabdomyolysis Weakness Severe weakness that led to patient not being able to get up from the floor earlier on the day of admission CPK 18K on admission Appreciate neurology follow-up. PT/OT  Parkinson's disease Continue home carbidopa levodopa, Artane Patient has had gradual weakness over the last few weeks.  Appreciate neurology follow-up , continue home medications and follow-up with neurology as outpatient.     Had brief episodes of altered state while inpatient likely due to acute infection versus steroid use.  Symptoms now resolved Outpatient follow-up with neurology
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Computerised tomogram neck, Computerised tomogram normal, Condition aggravated
Clinical narrative: HMS DISCHARGE SUMMARY -- Hospital     Admitted: 9/29/2023 Discharge Date: 10/02/23    PCP Handoff    Recommended Outpatient Testing o None   Results Pending At Discharge o None       Clinical Summary  Patient is a 72 y.o. male patient of MD with history of Parkinson's disease, hyperlipidemia presented to Hospital with cough, sore throat for a few days and severe weakness that started earlier today.  Found to be COVID positive at PCP office.  Found to have elevated CPK likely due to underlying COVID infection and decreased fluid intake.  CPK trending down with IV fluids.  Sore throat resolved.  Read by therapy with no further recommendations.  To be discharged home with outpatient follow-up   Covid-19 Virus Infection with pneumonia  Date of onset of symptoms: 9/27/23 Symptoms present on admission: Cough, sore throat Date of covid positive test: 9/29/23 Imaging: Chest x-ray 9/29 with minimal atelectasis of the left lung base Oxygen requirements on admission: None Current oxygen requirements: room air Medical therapy: Continued outpatient Paxlovid Anticipated special isolation end date: 10/7/23   Possible aspiration pneumonia/superimposed bacterial pneumonia Sepsis, POA (tachycardia, tachypnea, leukocytosis) Patient says he has some issues with swallowing related to the Parkinson's disease Weakness has been much worse due to the COVID Significant productive cough, sepsis on presentation Chest x-ray without any infiltrate CT soft tissue neck done for severe sore throat without any acute findings.  Blood cultures no growth today SLP consulted for swallow evaluation-appreciate recommendations.  No further speech therapy needs or diet modifications.   Rhabdomyolysis Weakness Severe weakness that led to patient not being able to get up from the floor earlier on the day of admission CPK 18K on admission Appreciate neurology follow-up. PT/OT  Parkinson's disease Continue home carbidopa levodopa, Artane Patient has had gradual weakness over the last few weeks.  Appreciate neurology follow-up , continue home medications and follow-up with neurology as outpatient.     Had brief episodes of altered state while inpatient likely due to acute infection versus steroid use.  Symptoms now resolved Outpatient follow-up with neurology
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dysphagia, Fluid intake reduced, Infection, Leukocytosis
Clinical narrative: HMS DISCHARGE SUMMARY -- Hospital     Admitted: 9/29/2023 Discharge Date: 10/02/23    PCP Handoff    Recommended Outpatient Testing o None   Results Pending At Discharge o None       Clinical Summary  Patient is a 72 y.o. male patient of MD with history of Parkinson's disease, hyperlipidemia presented to Hospital with cough, sore throat for a few days and severe weakness that started earlier today.  Found to be COVID positive at PCP office.  Found to have elevated CPK likely due to underlying COVID infection and decreased fluid intake.  CPK trending down with IV fluids.  Sore throat resolved.  Read by therapy with no further recommendations.  To be discharged home with outpatient follow-up   Covid-19 Virus Infection with pneumonia  Date of onset of symptoms: 9/27/23 Symptoms present on admission: Cough, sore throat Date of covid positive test: 9/29/23 Imaging: Chest x-ray 9/29 with minimal atelectasis of the left lung base Oxygen requirements on admission: None Current oxygen requirements: room air Medical therapy: Continued outpatient Paxlovid Anticipated special isolation end date: 10/7/23   Possible aspiration pneumonia/superimposed bacterial pneumonia Sepsis, POA (tachycardia, tachypnea, leukocytosis) Patient says he has some issues with swallowing related to the Parkinson's disease Weakness has been much worse due to the COVID Significant productive cough, sepsis on presentation Chest x-ray without any infiltrate CT soft tissue neck done for severe sore throat without any acute findings.  Blood cultures no growth today SLP consulted for swallow evaluation-appreciate recommendations.  No further speech therapy needs or diet modifications.   Rhabdomyolysis Weakness Severe weakness that led to patient not being able to get up from the floor earlier on the day of admission CPK 18K on admission Appreciate neurology follow-up. PT/OT  Parkinson's disease Continue home carbidopa levodopa, Artane Patient has had gradual weakness over the last few weeks.  Appreciate neurology follow-up , continue home medications and follow-up with neurology as outpatient.     Had brief episodes of altered state while inpatient likely due to acute infection versus steroid use.  Symptoms now resolved Outpatient follow-up with neurology
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Oropharyngeal pain, Productive cough, Rhabdomyolysis, SARS-CoV-2 test positive
Clinical narrative: HMS DISCHARGE SUMMARY -- Hospital     Admitted: 9/29/2023 Discharge Date: 10/02/23    PCP Handoff    Recommended Outpatient Testing o None   Results Pending At Discharge o None       Clinical Summary  Patient is a 72 y.o. male patient of MD with history of Parkinson's disease, hyperlipidemia presented to Hospital with cough, sore throat for a few days and severe weakness that started earlier today.  Found to be COVID positive at PCP office.  Found to have elevated CPK likely due to underlying COVID infection and decreased fluid intake.  CPK trending down with IV fluids.  Sore throat resolved.  Read by therapy with no further recommendations.  To be discharged home with outpatient follow-up   Covid-19 Virus Infection with pneumonia  Date of onset of symptoms: 9/27/23 Symptoms present on admission: Cough, sore throat Date of covid positive test: 9/29/23 Imaging: Chest x-ray 9/29 with minimal atelectasis of the left lung base Oxygen requirements on admission: None Current oxygen requirements: room air Medical therapy: Continued outpatient Paxlovid Anticipated special isolation end date: 10/7/23   Possible aspiration pneumonia/superimposed bacterial pneumonia Sepsis, POA (tachycardia, tachypnea, leukocytosis) Patient says he has some issues with swallowing related to the Parkinson's disease Weakness has been much worse due to the COVID Significant productive cough, sepsis on presentation Chest x-ray without any infiltrate CT soft tissue neck done for severe sore throat without any acute findings.  Blood cultures no growth today SLP consulted for swallow evaluation-appreciate recommendations.  No further speech therapy needs or diet modifications.   Rhabdomyolysis Weakness Severe weakness that led to patient not being able to get up from the floor earlier on the day of admission CPK 18K on admission Appreciate neurology follow-up. PT/OT  Parkinson's disease Continue home carbidopa levodopa, Artane Patient has had gradual weakness over the last few weeks.  Appreciate neurology follow-up , continue home medications and follow-up with neurology as outpatient.     Had brief episodes of altered state while inpatient likely due to acute infection versus steroid use.  Symptoms now resolved Outpatient follow-up with neurology
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis, Tachycardia, Tachypnoea
Clinical narrative: HMS DISCHARGE SUMMARY -- Hospital     Admitted: 9/29/2023 Discharge Date: 10/02/23    PCP Handoff    Recommended Outpatient Testing o None   Results Pending At Discharge o None       Clinical Summary  Patient is a 72 y.o. male patient of MD with history of Parkinson's disease, hyperlipidemia presented to Hospital with cough, sore throat for a few days and severe weakness that started earlier today.  Found to be COVID positive at PCP office.  Found to have elevated CPK likely due to underlying COVID infection and decreased fluid intake.  CPK trending down with IV fluids.  Sore throat resolved.  Read by therapy with no further recommendations.  To be discharged home with outpatient follow-up   Covid-19 Virus Infection with pneumonia  Date of onset of symptoms: 9/27/23 Symptoms present on admission: Cough, sore throat Date of covid positive test: 9/29/23 Imaging: Chest x-ray 9/29 with minimal atelectasis of the left lung base Oxygen requirements on admission: None Current oxygen requirements: room air Medical therapy: Continued outpatient Paxlovid Anticipated special isolation end date: 10/7/23   Possible aspiration pneumonia/superimposed bacterial pneumonia Sepsis, POA (tachycardia, tachypnea, leukocytosis) Patient says he has some issues with swallowing related to the Parkinson's disease Weakness has been much worse due to the COVID Significant productive cough, sepsis on presentation Chest x-ray without any infiltrate CT soft tissue neck done for severe sore throat without any acute findings.  Blood cultures no growth today SLP consulted for swallow evaluation-appreciate recommendations.  No further speech therapy needs or diet modifications.   Rhabdomyolysis Weakness Severe weakness that led to patient not being able to get up from the floor earlier on the day of admission CPK 18K on admission Appreciate neurology follow-up. PT/OT  Parkinson's disease Continue home carbidopa levodopa, Artane Patient has had gradual weakness over the last few weeks.  Appreciate neurology follow-up , continue home medications and follow-up with neurology as outpatient.     Had brief episodes of altered state while inpatient likely due to acute infection versus steroid use.  Symptoms now resolved Outpatient follow-up with neurology
Age: 77.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Musculoskeletal stiffness, Myalgia, Paraesthesia
Clinical narrative: This morning, I have been turning my arm and shoulder, and its pain in the joint and stuff. I have the tingling in my leg and hand and a little muscle pain around my shoulder and it's tingling too.
Age: 53.0
Sex: F
Vaccine: FLU4
Symptoms: Haematoma, Pain in extremity, Swelling
Clinical narrative: swelling hematoma and severe arms pain
Age: 80.0
Sex: F
Vaccine: RSV
Symptoms: Pain, Rash erythematous
Clinical narrative: PATIENT DEVELOPED A SMALL RED RASH WITH A SMALL AMOUNT OF PAIN STILL PRESENT 6 WEEKS AFTER IMMUNIZATION. PATIENT SAW HER DOCTOR, DOCTOR RECOMMENDED WAMR COMPRESSES AND BENADRYL FOR THE TIME BEING.
Age: 73.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Abdominal pain, Amnesia, Blood creatinine increased, Blood fibrinogen increased, Blood lactate dehydrogenase increased
Clinical narrative: Clinical course at hospital indicative of the development of sepsis and TTP-HUS (thrombotic thrombocytopenia purpura with hemolytic uremic syndrome).  Pt received dose 5 booster shot on 10/15/2023 (LOT #GJ6665).  Dose number 6 was given on 10/21/2023. Pts husband reported pt started feeling unwell the night of 10/21/23.  Pt presented to the ED on 10/25/23 C/O abdominal pain and rectal bleeding. Pt was Dx with Colitis and D/C with Bactrim PO ABX.  Per Pts husband pt continued to deteriorate at home. Pts husband called 911 on the morning of 10/29/2023 stating that pt did not recognize him and was nearly unresponsive.  Upon admission to the hospital Pt was in renal failure and had no purposeful neurologic movement. Pts husband moved to comfort care on 10/30/2023 when PT was rapidly deteriorating and was moving towards needing intubation and ICU level of care. The need for Plasmapheresis was being discussed when she moved towards comfort care.  Final diagnosis was not achieved because all of the diagnostic labwork was not able to be obtained.  however what was obtained was highly abnormal and leaning towards TTP-HUS.  Source of sepsis was unknown at the time she was moved to comfort care. The majority of labwork was hard to obtain because it was all coming back hemolyzed.
Age: 73.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Blood lactic acid, Carbon dioxide decreased, Colitis, Fibrin D dimer, General physical health deterioration
Clinical narrative: Clinical course at hospital indicative of the development of sepsis and TTP-HUS (thrombotic thrombocytopenia purpura with hemolytic uremic syndrome).  Pt received dose 5 booster shot on 10/15/2023 (LOT #GJ6665).  Dose number 6 was given on 10/21/2023. Pts husband reported pt started feeling unwell the night of 10/21/23.  Pt presented to the ED on 10/25/23 C/O abdominal pain and rectal bleeding. Pt was Dx with Colitis and D/C with Bactrim PO ABX.  Per Pts husband pt continued to deteriorate at home. Pts husband called 911 on the morning of 10/29/2023 stating that pt did not recognize him and was nearly unresponsive.  Upon admission to the hospital Pt was in renal failure and had no purposeful neurologic movement. Pts husband moved to comfort care on 10/30/2023 when PT was rapidly deteriorating and was moving towards needing intubation and ICU level of care. The need for Plasmapheresis was being discussed when she moved towards comfort care.  Final diagnosis was not achieved because all of the diagnostic labwork was not able to be obtained.  however what was obtained was highly abnormal and leaning towards TTP-HUS.  Source of sepsis was unknown at the time she was moved to comfort care. The majority of labwork was hard to obtain because it was all coming back hemolyzed.
Age: 73.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Haemolysis, Haemolytic uraemic syndrome, Hyporesponsive to stimuli, Laboratory test abnormal, Malaise
Clinical narrative: Clinical course at hospital indicative of the development of sepsis and TTP-HUS (thrombotic thrombocytopenia purpura with hemolytic uremic syndrome).  Pt received dose 5 booster shot on 10/15/2023 (LOT #GJ6665).  Dose number 6 was given on 10/21/2023. Pts husband reported pt started feeling unwell the night of 10/21/23.  Pt presented to the ED on 10/25/23 C/O abdominal pain and rectal bleeding. Pt was Dx with Colitis and D/C with Bactrim PO ABX.  Per Pts husband pt continued to deteriorate at home. Pts husband called 911 on the morning of 10/29/2023 stating that pt did not recognize him and was nearly unresponsive.  Upon admission to the hospital Pt was in renal failure and had no purposeful neurologic movement. Pts husband moved to comfort care on 10/30/2023 when PT was rapidly deteriorating and was moving towards needing intubation and ICU level of care. The need for Plasmapheresis was being discussed when she moved towards comfort care.  Final diagnosis was not achieved because all of the diagnostic labwork was not able to be obtained.  however what was obtained was highly abnormal and leaning towards TTP-HUS.  Source of sepsis was unknown at the time she was moved to comfort care. The majority of labwork was hard to obtain because it was all coming back hemolyzed.
Age: 73.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Nervous system disorder, Rectal haemorrhage, Renal failure, Sepsis, Thrombotic thrombocytopenic purpura
Clinical narrative: Clinical course at hospital indicative of the development of sepsis and TTP-HUS (thrombotic thrombocytopenia purpura with hemolytic uremic syndrome).  Pt received dose 5 booster shot on 10/15/2023 (LOT #GJ6665).  Dose number 6 was given on 10/21/2023. Pts husband reported pt started feeling unwell the night of 10/21/23.  Pt presented to the ED on 10/25/23 C/O abdominal pain and rectal bleeding. Pt was Dx with Colitis and D/C with Bactrim PO ABX.  Per Pts husband pt continued to deteriorate at home. Pts husband called 911 on the morning of 10/29/2023 stating that pt did not recognize him and was nearly unresponsive.  Upon admission to the hospital Pt was in renal failure and had no purposeful neurologic movement. Pts husband moved to comfort care on 10/30/2023 when PT was rapidly deteriorating and was moving towards needing intubation and ICU level of care. The need for Plasmapheresis was being discussed when she moved towards comfort care.  Final diagnosis was not achieved because all of the diagnostic labwork was not able to be obtained.  however what was obtained was highly abnormal and leaning towards TTP-HUS.  Source of sepsis was unknown at the time she was moved to comfort care. The majority of labwork was hard to obtain because it was all coming back hemolyzed.
Age: 73.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: White blood cell count increased
Clinical narrative: Clinical course at hospital indicative of the development of sepsis and TTP-HUS (thrombotic thrombocytopenia purpura with hemolytic uremic syndrome).  Pt received dose 5 booster shot on 10/15/2023 (LOT #GJ6665).  Dose number 6 was given on 10/21/2023. Pts husband reported pt started feeling unwell the night of 10/21/23.  Pt presented to the ED on 10/25/23 C/O abdominal pain and rectal bleeding. Pt was Dx with Colitis and D/C with Bactrim PO ABX.  Per Pts husband pt continued to deteriorate at home. Pts husband called 911 on the morning of 10/29/2023 stating that pt did not recognize him and was nearly unresponsive.  Upon admission to the hospital Pt was in renal failure and had no purposeful neurologic movement. Pts husband moved to comfort care on 10/30/2023 when PT was rapidly deteriorating and was moving towards needing intubation and ICU level of care. The need for Plasmapheresis was being discussed when she moved towards comfort care.  Final diagnosis was not achieved because all of the diagnostic labwork was not able to be obtained.  however what was obtained was highly abnormal and leaning towards TTP-HUS.  Source of sepsis was unknown at the time she was moved to comfort care. The majority of labwork was hard to obtain because it was all coming back hemolyzed.
Age: 71.0
Sex: F
Vaccine: RSV
Symptoms: Chills, Fatigue, Injection site erythema, Injection site swelling, Pain
Clinical narrative: Fever 100 degrees, red swelling at injection site, chills, full body aches, fatigue
Age: 18.0
Sex: F
Vaccine: MENB
Symptoms: Injection site erythema, Injection site exfoliation, Injection site reaction, Injection site swelling, Pain in extremity
Clinical narrative: Injection site reaction, sore arm, large red bump at injection site, scaly skin at swollen area
Age: 10.0
Sex: F
Vaccine: FLU4
Symptoms: Dyspnoea, Feeling abnormal
Clinical narrative: I was contact from the school secretary that the child was feeling short of breath after receiving the flu vaccine. They were able to assist her to the ground, laid her down and applied a cool wash cloth to her head. I instructed her to check the child's oxygen level and continue to monitor and let me know what the results were. Her sats were fine, she continued not to feel good, so they called the child's mother and she went home for the day. No other information or symptoms were reported thereafter. Prior to the injection the child was anxious, crying and did not want to receive the injection as she was scared.
Age: 64.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Lip swelling, Peripheral swelling, Swelling, Swelling face
Clinical narrative: Patient complaint of swelling in left arm (COVID vaccine) some on date shot was given 10/30/2023. Then upon wakening on 10/31/23, patient noticed swelling in neck, face, and lips. She stated she thought it was slightly improving. Patient was instructed to take benadryl and contact her PCP. The pharmacy also reached out to the PCP (per nurse) to inform them of the reaction. Patient received Spikevax 23-24 on 10/30/23 and has received the Moderna vaccine in the past without issue
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalized with COVID, fully vaccinated with boosters
Age: 4.0
Sex: M
Vaccine: DTAPIPV, FLU4, MMRV
Symptoms: Abdominal pain, Cough, Diarrhoea, Nausea, Pulse abnormal
Clinical narrative: Patient started coughing within about 5 minutes of getting his shots.  Felt like he was going to throw up, some dry heaving.  Belly hurt, smear of loose stool .  Throat felt tight.  Lungs clear prior to shots but diffuse wheezing and mild retractions after.  Pulse always brisk.  Got 2.5 mg albuterol and 0.5 mg atrovent nebs, 0.15 mg epi pen jr, and 10 ml of liquid benadryl.  EMT arrived and transported him Hospital for further managment.  Known egg allergy but not anaphylactic.  Has had both MMR and flu shots in the past with no problems
Age: 4.0
Sex: M
Vaccine: DTAPIPV, FLU4, MMRV
Symptoms: Retching, Throat tightness, Use of accessory respiratory muscles, Wheezing
Clinical narrative: Patient started coughing within about 5 minutes of getting his shots.  Felt like he was going to throw up, some dry heaving.  Belly hurt, smear of loose stool .  Throat felt tight.  Lungs clear prior to shots but diffuse wheezing and mild retractions after.  Pulse always brisk.  Got 2.5 mg albuterol and 0.5 mg atrovent nebs, 0.15 mg epi pen jr, and 10 ml of liquid benadryl.  EMT arrived and transported him Hospital for further managment.  Known egg allergy but not anaphylactic.  Has had both MMR and flu shots in the past with no problems
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Injection site erythema, Injection site pain, Injection site reaction, Muscle spasms
Clinical narrative: Sore, redened at injection site; progressed to muscle cramping through arm above injection site and to rear of back. Continues to the present time ( 30 days).  Treatment- occasional Tylenol & hot compress
Age: 15.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Erythema, Nasopharyngitis, Pyrexia, Swelling face
Clinical narrative: Facial redness/swelling, low grade fever.  cold like symptoms onset one day after vaccination
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Extra dose administered, Headache, Product administration error
Clinical narrative: on 10/26/23 patient called pharmacy and asked if he complete his series of 2  shingrix doses because his doctor office alerted him that they have no record of his vaccination the pharmacist check pt's file also the wed site but found only 1 dose completed.  The pharmacist gave pt the shingrix vaccine on that same morning as his second dose on 10/29/23 the pharmacist thought about his case and looked all over the paper signed by pt when he received his vaccines and found that he already received 2 dose in 2021 1st: 05/22/2021 2nd: 07/24/2021 The pharmacist immediately informed the pt about the error that the pharmacist gave him an extra dose (3rd) on 10/26/2023 pharmascist appologized pt for the mistake and follow up with him about side affect that he might expericened. The pt stated that he had a severe headache the night of 10/26/23 but he felft better and better every day after, however on 10/30/23  pt stated that sometimes he still feel headache. pharmacist advised him to take tylenol, take orange juice and water to help him with the symptom. 10/30/23 pharmacist contacted the dr (pt's pcp) and spoke to staff about the administration error. Dr message to the pharmacist that was OK and she is aware of the event Will follow up with pt regarding his headache
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: MENVEO ADMINISTERED 60 DAYS AFTER 1ST DOSE. THIS IS AN INVALID DOSE.
Age: 57.0
Sex: F
Vaccine: RSV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Arexvy administered to 57 y.o. Not indicated until age 60.  No known outcomes or adverse effect
Age: 64.0
Sex: M
Vaccine: UNK
Symptoms: Abdominal pain upper, Blood test, Influenza like illness, Magnetic resonance imaging, Pain
Clinical narrative: Had severe stomach pain for 30 hours #10 pain and flu like symptoms went to ER
Age: 51.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: About two hours post vaccine patient presented to nurse with a rash that presented on her right arm. rash was itchy and had a red and hive type appearance. Provider in the clinic advised 25 mg oral Benadryl.
Age: 7.0
Sex: F
Vaccine: DTAP
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: DTap vaccine given to patient over the age of 7 years old.  Reviewed with provider who stated that the vaccine was ordered because the fourth dose of DTap on record was given before the child was 4 years old.
Age: 63.0
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Not an age-appropriate vaccine
Age: 62.0
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Not an age-appropriate vaccine
Age: 55.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Urticaria
Clinical narrative: 24 hours after receiving the vaccine patient developed a large welt on her left arm, it was present for 3-4 days before resolving
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: 0.25 ml of Pediatric covid-19 vaccine was given to adult. After notifying supervisors and Dr., Patients were called back to receive 0.25 ml of adult Covid-19 vaccine. Patient did not have a reaction to this medication.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal pain, Chest X-ray, Electrocardiogram, Full blood count, Metabolic function test
Clinical narrative: Abdominal pain lasting 7 hours, 5 of those hours severe.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Myocardial necrosis marker
Clinical narrative: Abdominal pain lasting 7 hours, 5 of those hours severe.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Cervicogenic headache, Condition aggravated, Neck pain
Clinical narrative: REceived SHingrix vaccination at Pharmacy. 4 hours later had sudden onset increase in cervicogenic headache and cervicalgia pain.  Reduced in intensity after the initial 24 hours, still with increased neck pain flare after 5 days.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 0.25 ml of Pediatric covid-19 vaccine was given to adult. After notifying supervisors and Dr., Patients were called back to receive 0.25 ml of adult Covid-19 vaccine. No adverse reactions
Age: 75.0
Sex: F
Vaccine: RSV, RSV
Symptoms: Immune thrombocytopenia, Immunoglobulin therapy, Platelet count decreased
Clinical narrative: Patient received RSV vaccine on 10/10, then on 10/20 for routine visit, platelet value was 6. Repeat platelet count was 6.  Suspected immune thrombocytopenia due to RSV vaccine due to timeframe and no other identifying causes.  Prior platelet levels from a visit month before was 132. Prior monthly values were 166, then 148, and 132 without count check in between.   Patient was admitted to the hospital and treated with dexamethasone 40 mg x 3 days + IVIG 1g/kg x 2 doses. Platelet count subsequently improved to 25 on 10/21/23 after treatment, with most recent platelet count of 74 on 10/27.
Age: 75.0
Sex: F
Vaccine: RSV, RSV
Symptoms: Immune thrombocytopenia, Platelet count decreased
Clinical narrative: Patient received RSV vaccine on 10/10, then on 10/20 for routine visit, platelet value was 6. Repeat platelet count was 6.  Suspected immune thrombocytopenia due to RSV vaccine due to timeframe and no other identifying causes.  Prior platelet levels from a visit month before was 132. Prior monthly values were 166, then 148, and 132 without count check in between.   Patient was admitted to the hospital and treated with dexamethasone 40 mg x 3 days + IVIG 1g/kg x 2 doses. Platelet count subsequently improved to 25 on 10/21/23 after treatment, with most recent platelet count of 74 on 10/27.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 0.25 ml of Pediatric covid-19 vaccine was given to adult. After notifying supervisors and Dr., Patients were called back to receive 0.25 ml of adult Covid-19 vaccine. Patient did not have any adverse reactions.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 0.25 ml of Pediatric covid-19 vaccine was given to adult. After notifying supervisors and Dr., Patients were called back to receive 0.25 ml of adult Covid-19 vaccine. Patient did not have any adverse reactions.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Muscle twitching, Pyrexia
Clinical narrative: Mom reported at the 6 month check up he had a fever to 104 and twitching movements the same day of vaccinations.  She also reported that he still have some twitching movements.
Age: 66.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Wrong product administered
Clinical narrative: Patient requested RSV but vaccines entered for flu and covid.  Pharmacist did say I have your flu and covid.  After the vaccines were administered patient says "Was that was my RSV?"
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 0.25 ml of Pediatric covid-19 vaccine was given to adult. After notifying supervisors and Dr. Patients were called back to receive 0.25 ml of adult Covid-19 vaccine. Patient did not have any adverse reactions.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: No adverse effects reported. FDA approved the 2023-2024 Monovalent COVID-19 vaccine and no longer authorized the Bivalent COVID-19 vaccine on 9-11-2023. ACIP meeting for approval was 9-12-2023. Patient was given the Bivalent COVID-19 vaccine on 9-13-2023, prior to knowing of the official change in recommendations. Patient notified by nurse to return in 2 months for the new monovalent 2023-2024 COVID-19 vaccine.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Influenza like illness, Insomnia, Pain, Pain in extremity
Clinical narrative: severe pain in arm and left side chills flueish feeling could knot sleep aches and pain throout entire body
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Underdose
Clinical narrative: 0.25 ml of Pediatric covid-19 vaccine was given to adult. After notifying supervisors and Dr., Patients were called back to receive 0.25 ml of adult Covid-19 vaccine. Patient did not have any adverse reactions.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product administered to patient of inappropriate age
Clinical narrative: 0.25 ml of Pediatric covid-19 vaccine was given to adult. After notifying supervisors and Dr. Patients were called back to receive 0.25 ml of adult Covid-19 vaccine. Patient did not have any adverse reactions.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Feeling hot, Nausea, Pyrexia
Clinical narrative: Patient reported that within 12 hours of receiving vaccines, patient got a major burning on the arm (received administration), burning up, chills then feeling nauseous so rushed to bathroom. No vomiting. Temp > 101.4F , her symptoms lasted for 5 to 6 hours.
Age: 0.33
Sex: M
Vaccine: RV5
Symptoms: Barium double contrast, Crying, Discoloured vomit, Haematochezia, Infant irritability
Clinical narrative: Patient was in his usual state of health until the the middle of the night when he became very fussy, crying for 10 to 15-minutes.  Piercing cries.  He developed vomiting about 4-5 times, described as yellow in color.  He was seen at ER and an ultrasound showed ileocolic intussusception.  He was transferred to main campus ED for air enema to correct the intussusception.  He received Zofran and normal saline bolus.  In route, he had 1 episode of vomiting that is yellow in color.  He also had a stool that was bloody.  Enema successful and patient discharged.
Age: 0.33
Sex: M
Vaccine: RV5
Symptoms: Intussusception, Ultrasound abdomen abnormal
Clinical narrative: Patient was in his usual state of health until the the middle of the night when he became very fussy, crying for 10 to 15-minutes.  Piercing cries.  He developed vomiting about 4-5 times, described as yellow in color.  He was seen at ER and an ultrasound showed ileocolic intussusception.  He was transferred to main campus ED for air enema to correct the intussusception.  He received Zofran and normal saline bolus.  In route, he had 1 episode of vomiting that is yellow in color.  He also had a stool that was bloody.  Enema successful and patient discharged.
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Discontinued product administered, No adverse event
Clinical narrative: No adverse effects reported. FDA approved the 2023-2024 Monovalent COVID-19 vaccine and no longer authorized the Bivalent COVID-19 vaccine on 9-11-2023. ACIP meeting for approval was 9-12-2023. Patient was given the Bivalent COVID-19 vaccine on 9-13-2023, prior to knowing of the official change in recommendations. Patient notified by nurse to return in 2 months for the new monovalent 2023-2024 COVID-19 vaccine.